Report Detail

Medical Devices & Consumables Global Chronic Heart Failure (CHF) Devices Sales Market Report 2021

  • RnM4075198
  • |
  • 22 June, 2021
  • |
  • Global
  • |
  • 145 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

The global Chronic Heart Failure (CHF) Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Heart Failure (CHF) Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps

Segment by Application
Hospital
Clinic
Household
Others

The Chronic Heart Failure (CHF) Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Chronic Heart Failure (CHF) Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart


1 Chronic Heart Failure (CHF) Devices Market Overview

  • 1.1 Chronic Heart Failure (CHF) Devices Product Scope
  • 1.2 Chronic Heart Failure (CHF) Devices Segment by Type
    • 1.2.1 Global Chronic Heart Failure (CHF) Devices Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Implantable Left Ventricular Assist Device (LVAD)
    • 1.2.3 Biventricular Pacemaker
    • 1.2.4 Implantable Cardioverter-defibrillators (ICDs)
    • 1.2.5 Continuous Positive Air Pressure Device (CPAP)
    • 1.2.6 Bi-level Positive Air Pressure Device (BiPAP)
    • 1.2.7 Heart Pumps
  • 1.3 Chronic Heart Failure (CHF) Devices Segment by Application
    • 1.3.1 Global Chronic Heart Failure (CHF) Devices Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Household
    • 1.3.5 Others
  • 1.4 Chronic Heart Failure (CHF) Devices Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Chronic Heart Failure (CHF) Devices Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Chronic Heart Failure (CHF) Devices Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Chronic Heart Failure (CHF) Devices Price Trends (2016-2027)

2 Chronic Heart Failure (CHF) Devices Estimates and Forecasts by Region

  • 2.1 Global Chronic Heart Failure (CHF) Devices Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Chronic Heart Failure (CHF) Devices Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2016-2021)
  • 2.3 Global Chronic Heart Failure (CHF) Devices Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Chronic Heart Failure (CHF) Devices Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Chronic Heart Failure (CHF) Devices Estimates and Projections (2016-2027)
    • 2.4.2 Europe Chronic Heart Failure (CHF) Devices Estimates and Projections (2016-2027)
    • 2.4.3 China Chronic Heart Failure (CHF) Devices Estimates and Projections (2016-2027)
    • 2.4.4 Japan Chronic Heart Failure (CHF) Devices Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Chronic Heart Failure (CHF) Devices Estimates and Projections (2016-2027)
    • 2.4.6 India Chronic Heart Failure (CHF) Devices Estimates and Projections (2016-2027)

3 Global Chronic Heart Failure (CHF) Devices Competition Landscape by Players

  • 3.1 Global Top Chronic Heart Failure (CHF) Devices Players by Sales (2016-2021)
  • 3.2 Global Top Chronic Heart Failure (CHF) Devices Players by Revenue (2016-2021)
  • 3.3 Global Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Heart Failure (CHF) Devices as of 2020)
  • 3.4 Global Chronic Heart Failure (CHF) Devices Average Price by Company (2016-2021)
  • 3.5 Manufacturers Chronic Heart Failure (CHF) Devices Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Chronic Heart Failure (CHF) Devices Market Size by Type

  • 4.1 Global Chronic Heart Failure (CHF) Devices Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Chronic Heart Failure (CHF) Devices Price by Type (2016-2021)
  • 4.2 Global Chronic Heart Failure (CHF) Devices Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Chronic Heart Failure (CHF) Devices Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Chronic Heart Failure (CHF) Devices Price Forecast by Type (2022-2027)

5 Global Chronic Heart Failure (CHF) Devices Market Size by Application

  • 5.1 Global Chronic Heart Failure (CHF) Devices Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Chronic Heart Failure (CHF) Devices Price by Application (2016-2021)
  • 5.2 Global Chronic Heart Failure (CHF) Devices Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Chronic Heart Failure (CHF) Devices Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Chronic Heart Failure (CHF) Devices Price Forecast by Application (2022-2027)

6 North America Chronic Heart Failure (CHF) Devices Market Facts & Figures

  • 6.1 North America Chronic Heart Failure (CHF) Devices Sales by Company
    • 6.1.1 North America Chronic Heart Failure (CHF) Devices Sales by Company (2016-2021)
    • 6.1.2 North America Chronic Heart Failure (CHF) Devices Revenue by Company (2016-2021)
  • 6.2 North America Chronic Heart Failure (CHF) Devices Sales Breakdown by Type
    • 6.2.1 North America Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2022-2027)
  • 6.3 North America Chronic Heart Failure (CHF) Devices Sales Breakdown by Application
    • 6.3.1 North America Chronic Heart Failure (CHF) Devices Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Chronic Heart Failure (CHF) Devices Sales Breakdown by Application (2022-2027)

7 Europe Chronic Heart Failure (CHF) Devices Market Facts & Figures

  • 7.1 Europe Chronic Heart Failure (CHF) Devices Sales by Company
    • 7.1.1 Europe Chronic Heart Failure (CHF) Devices Sales by Company (2016-2021)
    • 7.1.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Company (2016-2021)
  • 7.2 Europe Chronic Heart Failure (CHF) Devices Sales Breakdown by Type
    • 7.2.1 Europe Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Chronic Heart Failure (CHF) Devices Sales Breakdown by Application
    • 7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Chronic Heart Failure (CHF) Devices Market Facts & Figures

  • 8.1 China Chronic Heart Failure (CHF) Devices Sales by Company
    • 8.1.1 China Chronic Heart Failure (CHF) Devices Sales by Company (2016-2021)
    • 8.1.2 China Chronic Heart Failure (CHF) Devices Revenue by Company (2016-2021)
  • 8.2 China Chronic Heart Failure (CHF) Devices Sales Breakdown by Type
    • 8.2.1 China Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2022-2027)
  • 8.3 China Chronic Heart Failure (CHF) Devices Sales Breakdown by Application
    • 8.3.1 China 313 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Chronic Heart Failure (CHF) Devices Market Facts & Figures

  • 9.1 Japan Chronic Heart Failure (CHF) Devices Sales by Company
    • 9.1.1 Japan Chronic Heart Failure (CHF) Devices Sales by Company (2016-2021)
    • 9.1.2 Japan Chronic Heart Failure (CHF) Devices Revenue by Company (2016-2021)
  • 9.2 Japan Chronic Heart Failure (CHF) Devices Sales Breakdown by Type
    • 9.2.1 Japan Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Chronic Heart Failure (CHF) Devices Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Chronic Heart Failure (CHF) Devices Market Facts & Figures

  • 10.1 Southeast Asia Chronic Heart Failure (CHF) Devices Sales by Company
    • 10.1.1 Southeast Asia Chronic Heart Failure (CHF) Devices Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Chronic Heart Failure (CHF) Devices Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Breakdown by Type
    • 10.2.1 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Chronic Heart Failure (CHF) Devices Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Chronic Heart Failure (CHF) Devices Market Facts & Figures

  • 11.1 India Chronic Heart Failure (CHF) Devices Sales by Company
    • 11.1.1 India Chronic Heart Failure (CHF) Devices Sales by Company (2016-2021)
    • 11.1.2 India Chronic Heart Failure (CHF) Devices Revenue by Company (2016-2021)
  • 11.2 India Chronic Heart Failure (CHF) Devices Sales Breakdown by Type
    • 11.2.1 India Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Chronic Heart Failure (CHF) Devices Sales Breakdown by Type (2022-2027)
  • 11.3 India Chronic Heart Failure (CHF) Devices Sales Breakdown by Application
    • 11.3.1 India Chronic Heart Failure (CHF) Devices Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Chronic Heart Failure (CHF) Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Chronic Heart Failure (CHF) Devices Business

  • 12.1 Medtronic
    • 12.1.1 Medtronic Corporation Information
    • 12.1.2 Medtronic Business Overview
    • 12.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Medtronic Chronic Heart Failure (CHF) Devices Products Offered
    • 12.1.5 Medtronic Recent Development
  • 12.2 Abbott
    • 12.2.1 Abbott Corporation Information
    • 12.2.2 Abbott Business Overview
    • 12.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Abbott Chronic Heart Failure (CHF) Devices Products Offered
    • 12.2.5 Abbott Recent Development
  • 12.3 Johnson & Johnson
    • 12.3.1 Johnson & Johnson Corporation Information
    • 12.3.2 Johnson & Johnson Business Overview
    • 12.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Johnson & Johnson Chronic Heart Failure (CHF) Devices Products Offered
    • 12.3.5 Johnson & Johnson Recent Development
  • 12.4 Stanley Pharmaceuticals
    • 12.4.1 Stanley Pharmaceuticals Corporation Information
    • 12.4.2 Stanley Pharmaceuticals Business Overview
    • 12.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Products Offered
    • 12.4.5 Stanley Pharmaceuticals Recent Development
  • 12.5 New Haven Pharmaceuticals, Inc.
    • 12.5.1 New Haven Pharmaceuticals, Inc. Corporation Information
    • 12.5.2 New Haven Pharmaceuticals, Inc. Business Overview
    • 12.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Products Offered
    • 12.5.5 New Haven Pharmaceuticals, Inc. Recent Development
  • 12.6 Boston Scientific Corporation
    • 12.6.1 Boston Scientific Corporation Corporation Information
    • 12.6.2 Boston Scientific Corporation Business Overview
    • 12.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Products Offered
    • 12.6.5 Boston Scientific Corporation Recent Development
  • 12.7 HeartWare
    • 12.7.1 HeartWare Corporation Information
    • 12.7.2 HeartWare Business Overview
    • 12.7.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 HeartWare Chronic Heart Failure (CHF) Devices Products Offered
    • 12.7.5 HeartWare Recent Development
  • 12.8 Biovail Corporation
    • 12.8.1 Biovail Corporation Corporation Information
    • 12.8.2 Biovail Corporation Business Overview
    • 12.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Biovail Corporation Chronic Heart Failure (CHF) Devices Products Offered
    • 12.8.5 Biovail Corporation Recent Development
  • 12.9 Abiomed
    • 12.9.1 Abiomed Corporation Information
    • 12.9.2 Abiomed Business Overview
    • 12.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Abiomed Chronic Heart Failure (CHF) Devices Products Offered
    • 12.9.5 Abiomed Recent Development
  • 12.10 Symplmed Pharmaceuticals
    • 12.10.1 Symplmed Pharmaceuticals Corporation Information
    • 12.10.2 Symplmed Pharmaceuticals Business Overview
    • 12.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Products Offered
    • 12.10.5 Symplmed Pharmaceuticals Recent Development
  • 12.11 Berlin Heart GmbH
    • 12.11.1 Berlin Heart GmbH Corporation Information
    • 12.11.2 Berlin Heart GmbH Business Overview
    • 12.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Products Offered
    • 12.11.5 Berlin Heart GmbH Recent Development
  • 12.12 ReliantHeart, Inc.
    • 12.12.1 ReliantHeart, Inc. Corporation Information
    • 12.12.2 ReliantHeart, Inc. Business Overview
    • 12.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Products Offered
    • 12.12.5 ReliantHeart, Inc. Recent Development
  • 12.13 Cardiokinetix
    • 12.13.1 Cardiokinetix Corporation Information
    • 12.13.2 Cardiokinetix Business Overview
    • 12.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Cardiokinetix Chronic Heart Failure (CHF) Devices Products Offered
    • 12.13.5 Cardiokinetix Recent Development
  • 12.14 Biotronik
    • 12.14.1 Biotronik Corporation Information
    • 12.14.2 Biotronik Business Overview
    • 12.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Biotronik Chronic Heart Failure (CHF) Devices Products Offered
    • 12.14.5 Biotronik Recent Development
  • 12.15 Jarvik Heart
    • 12.15.1 Jarvik Heart Corporation Information
    • 12.15.2 Jarvik Heart Business Overview
    • 12.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Jarvik Heart Chronic Heart Failure (CHF) Devices Products Offered
    • 12.15.5 Jarvik Heart Recent Development

13 Chronic Heart Failure (CHF) Devices Manufacturing Cost Analysis

  • 13.1 Chronic Heart Failure (CHF) Devices Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices
  • 13.4 Chronic Heart Failure (CHF) Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Chronic Heart Failure (CHF) Devices Distributors List
  • 14.3 Chronic Heart Failure (CHF) Devices Customers

15 Market Dynamics

  • 15.1 Chronic Heart Failure (CHF) Devices Market Trends
  • 15.2 Chronic Heart Failure (CHF) Devices Drivers
  • 15.3 Chronic Heart Failure (CHF) Devices Market Challenges
  • 15.4 Chronic Heart Failure (CHF) Devices Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Chronic Heart Failure (CHF) Devices. Industry analysis & Market Report on Chronic Heart Failure (CHF) Devices is a syndicated market report, published as Global Chronic Heart Failure (CHF) Devices Sales Market Report 2021. It is complete Research Study and Industry Analysis of Chronic Heart Failure (CHF) Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,000.00
    $6,000.00
    $8,000.00
    3,084.00
    4,626.00
    6,168.00
    3,704.00
    5,556.00
    7,408.00
    612,960.00
    919,440.00
    1,225,920.00
    337,320.00
    505,980.00
    674,640.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report